tokens: The platelet membrane glycoprotein IIb / IIIa receptor inhibitor abciximab is used for the treatment of patients undergoing high - risk percutaneous coronary interventions and is used in approximately one third of coronary interventions in the United States and a growing number of procedures in Europe .